| Bergmann, Markus (CureVac 202203– Managing Director CureVac RNA Printer GmbH before ZF Group + Rools Royce + McKinsey) |
Managing Director |
CureVac (Group) |
Germany |
| Bergmann, Ralf (BIAS 201104 Managing Director) |
Managing Director |
BIAS Bremer Institut für angewandte Strahltechnik GmbH |
Germany |
| Bergmann, Thorald (Bergmann Messgeräte 1991– founder) |
Company Founder |
Bergmann Messgeräte Entwicklungs KG (BME) |
Germany |
| Bergo, Vladislav (Adeptrix 202101 CEO + Founder) |
Chief Executive Officer (CEO) |
Adeptrix Corporation |
United States (USA) |
| Bergsch, Manfred A. (AMETEK –201606 Managing Director SPECTRO GmbH RETIRED 7/16) |
Managing Director |
AMETEK (Group) |
Germany |
| Berka, Alexander (Analytik Jena 200512) |
n. a. |
Endress+Hauser (Group) |
Germany |
| Berka, Klaus (Analytik Jena 200702 Chairman Executive Board) |
Chief Executive Officer (CEO) |
Endress+Hauser (Group) |
Germany |
| Berking, Carola (LMU Munich 201202 Professor at Dept of Dermatology) |
Professor |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
| Berlin, Kurt (Epigenomics –200808 CSO + co-founder stepped down 8/08 + continued as Chair of Scientific Advisory Board) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Epigenomics (Group) |
Germany |
| Berlin, Vivian (Harvard Univ 201305 Director Business Developmet at Office of Technology Development) |
Business Development Manager / Strategy Manager |
Harvard University |
United States (USA) |
| Bermingham, Nessan (Khosla Ventures 202206 Partner before Intellia Therapeutics 201411– CEO + Co-founder) |
Chief Executive Officer (CEO) |
Khosla Ventures |
United States (USA) |
| Bern, Morten (Thermo Fisher 201510 Senior Director + General Manager GC-MS) |
General Manager (management) |
Thermo Fisher (Group) |
United States (USA) |
| Bernard, Christopher M. (Chris) (Curetis 2016Q2– CEO of Curetis USA before Epic Sciences + Metabolon + Abaxis + Cytyc) |
Sales Manager / Marketing Manager |
Metabolon (Group) |
United States (USA) |
| Bernard, Raphaël (GenomSys 201909 Marketing + Communications Manager) |
Sales Manager / Marketing Manager |
GenomSys S.A. |
Switzerland |
| Bernard, Thierry (Qiagen 201502– SVP Molecular Dx business area before bioMérieux Corp VP Commcercial Operations) |
President/Director/Head Business Group/Unit/Division |
Qiagen (Group) |
Netherlands |
| Bernasconi, Serge (Eucomed 201207– Chief Executive + EDMA 201207– Chief Executive before Medtronic France) |
Chief Executive Officer (CEO) |
Eucomed |
Belgium |
| Bernasconi, Stefano (ETH Zürich 201512 Professor) |
Professor |
ETH Zürich (ETHZ) |
Switzerland |
| Bernhardt, Ulrich (AnaKat Institut für Biotechnologie GmbH 200810 ) |
n. a. |
AnaKat Institut für Biotechnologie GmbH |
Germany |
| Berninger, Harald (Kreatech 200709– Sales + Marketing Director before Qiagen since 1993) |
Sales Manager / Marketing Manager |
Danaher (Group) |
Netherlands |
| Berns, Paul L. (ARCH Venture 202101 Partner previously Venture Partner before Anacor Pharmaceuticals + Allos Tx) |
Partner (venture partner) |
ARCH Venture (Group) |
United States (USA) |
| Bernstein, Gregory (EQT 202105 Investor + Venture Lead at EQT Ventures) |
Investment Manager |
EQT (Wallenberg family) (Group) |
Sweden |
| Berrebi, Sylvie (Huntsworth 201506 at Citigate Dewe Rogerson) |
Public Relations Manager / Investor Relations Manager |
Huntsworth (Group) |
United Kingdom (GB) |
| Berschauer, Friedrich (Bayer CropScience 200510 CEO) |
Chief Executive Officer (CEO) |
Bayer (Group) |
Germany |
| Bertarelli, Ernesto (Serono 200412 CEO + major owner) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Switzerland |
| Bertermann, Rüdiger (Univ Würzburg 201006 Dept of Inorganic Chemistry) |
Researcher (university / research institute) |
University of Würzburg |
Germany |
| Berth, Matthias (Decodon GmbH 201303 Managing Director) |
Managing Director |
Decodon GmbH |
Germany |
| Berthel, Holger (Meridian Bioscience 201110 Sales Manager Germany at Bioline GmbH) |
Sales Manager / Marketing Manager |
Meridian Bioscience (Group) |
Germany |
| Berthiaume, Douglas (Doug) (Waters 201509– Board Chairman before CEO) |
Board member, non-executive |
Waters (Group) |
United States (USA) |
| Berthold, Anselm (Berthold Detection Systems 200807 Managing Director + Owner) |
Managing Director |
Berthold Detection Systems (Group) |
Germany |
| Berthold, Michael R. (200609 Univ Konstanz Professor) |
Professor |
University of Constance (Universität Konstanz) |
Germany |
| Berthold, Thomas (Lifescience Business Consulting 201101– before JnJ) |
Consultant (economic/technology) |
Lifescience Business Consulting – Dr. Thomas Berthold |
Germany |
| Berthoux, Christophe (CiToxLab 201808– CEO Europe before Synexus 2010–2017 + Charles River 1990–2006) |
Chief Executive Officer (CEO) |
Synexus (Group) |
United Kingdom (GB) |
| Bertling, Wolf M. (November AG –200609 CEO change to Board of Directors) |
Chief Executive Officer (CEO) |
November (Group) |
Germany |
| Bertozzi, Carlo (G7 Therapeutics 201508 CEO) |
Chief Executive Officer (CEO) |
Sosei (Group) |
Switzerland |
| Bertram, Heinz-Jürgen (Symrise 201304 CEO) |
Chief Executive Officer (CEO) |
Symrise (Group) |
Germany |
| Bertram, Joachim (IBA GmbH 201412 Managing Director) |
Managing Director |
IBA GmbH (Group) |
Germany |
| Bertrand, Claude (Ipsen 200910– CSO before AstraZeneca SVP RnD before Pfizer + Roche + Ciba-Geigy) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Ipsen (Group) |
France |
| Bertschi, Mattia (Aktiia 201805– CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Aktiia S.A. |
Switzerland |
| Bertschinger, Julian (Covagen 200701– CEO + co-founder) |
Chief Executive Officer (CEO) |
Johnson & Johnson (JnJ) (Group) |
Switzerland |
| Besner, Hubert (WilmerHale Munich 200605) |
n. a. |
WilmerHale (Group) |
Germany |
| Besser, Daniel (German Stem Cell Network 202205 Managing Director) |
Managing Director |
German Stem Cell Network (GSCN, Deutsches Stammzellnetzwerk) |
Germany |
| Bethell, Ross (Centogene 201902 Director Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Centogene (Group) |
Germany |
| Bettecken, Beate (GoodVent 201109 Investment Manager) |
Investment Manager |
GoodVent Beteiligungsmanagement GmbH & Co KG |
Germany |
| Bettray, Wolfgang (RWTH Aachen 200910 Institute for Organic Chemistry Head Mass Spec) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
RWTH Aachen (Rheinisch-Westfälische Technische Hochschule Aachen) |
Germany |
| Betts, Katja (R-Biopharm 201904– Managing Director Commercial at Progen Biotechnik GmbH joined 2016) |
Managing Director |
R-Biopharm (Group) |
Germany |
| Betz, Ulrich (Merck (DE) 201507 Head Innvoation + Entrepreneurship Incubator at Merck Serono) |
Business Development Manager / Strategy Manager |
Merck (DE) (Group) |
Germany |
| Beule, Dieter (Microdiscovery 200501 Managing Director CTO + Co-Founder) |
Chief Technology/Technical Officer (CTO) |
MicroDiscovery GmbH |
Germany |
| Beutler, Martin (Bionsys GmbH 201006 Managing Director) |
Managing Director |
Bionsys GmbH |
Germany |
| Bevan, Paul (Wilex AG 200612 Head of RnD) |
Research & Development Manager |
Heidelberg Pharma (Group) |
Germany |
| Beyenburg, Rudolf (GE Healthcare Europe 200901) |
n. a. |
General Electric (Group) |
Germany |
| Beyer, Carsten (s.Pro GmbH 201204 Managing Director) |
Managing Director |
s.Pro – sustainable projects GmbH |
Germany |
| Beyer, Ingrid (Hadean Ventures 202110 Head of IR + Business Development) |
Public Relations Manager / Investor Relations Manager |
Hadean Ventures AS |
Norway |
| Beyer, Stefan (PHW Group 201102 Managing Director of Vibalogics GmbH) |
Managing Director |
Recipharm (Group) |
Germany |
| Beyreuther, Konrad (Univ Heidelberg ZMBH 1987–) |
n. a. |
University of Heidelberg (Ruperto Carola) |
Germany |
| Bhardwaj, Gunjan (Innoplexus 201107– CEO + Founder before Boston Consulting Group) |
Chief Executive Officer (CEO) |
Innoplexus (Group) |
Germany |
| Bhatia, Dhiren (Viewics 201711 President + Founder) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
United States (USA) |
| Bialojan, Siegfried (Ernst & Young) |
Consultant (economic/technology) |
Cap Gemini Ernst & Young (Group) |
Germany |
| Bicker, Uwe (Univ Heidelberg 1983 Professor at Medical Facility + Board Member) |
Professor |
University of Heidelberg (Ruperto Carola) |
Germany |
| Bickert, Stefan (Sensovation 201110 CEO) |
Chief Executive Officer (CEO) |
Miltenyi Biotec (Group) |
Germany |
| Biechl, Susanne (Maisberger 201403 Account Executive) |
Public Relations Manager / Investor Relations Manager |
Maisberger Gesellschaft für strategische Unternehmenskommunikation mbH |
Germany |
| Biegi, Thomas (MorphoSys 202012– Head of Corporate Communications before Pfizer + Daimler) |
Public Relations Manager / Investor Relations Manager |
MorphoSys (Group) |
Germany |
| Bier, Frank F. (Fraunhofer IBMT 200503) |
n. a. |
Fraunhofer (Group) |
Germany |
| Bieri, Christoph (Covalys 200502 CEO) |
Chief Executive Officer (CEO) |
Covalys Biosciences AG |
Switzerland |
| Biermann, Ferdinand (Fraunhofer IPT 202103 Head of Business Unit Life Sciences Engineering) |
President/Director/Head of Research Organisation/Unit |
Fraunhofer (Group) |
Germany |
| Bigalke, Hans (Toxogen GmbH 201103 Managing Director) |
Managing Director |
Toxogen GmbH |
Germany |
| Bigois, Mathieu (Ponthieu Partners 201702 Founder + European Venture Partner of ABG) |
Partner (venture partner) |
Ponthieu Partners (FR) |
Switzerland |
| Bihlmann, Heike (Swiss Biotech 201105) |
n. a. |
Swiss Biotech Association (SBA) |
Switzerland |
| Bijyohira, Arihiko (Chiome BIoscience 201710 Executive Director + CFO) |
Chief Financial Officer (CFO) |
Chiome Bioscience (Group) |
Japan |
| Bilenker, Josh (Loxo Oncology 201811 CEO) |
Chief Executive Officer (CEO) |
Eli Lilly (Group) |
United States (USA) |
| Bilitewski, U. (Helmholtz 201004 Professor Helmholtz Centre for Infection Research) |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Bille, Joachim (Secarna + Genova + Sterna Biologicals 201604 Managing Director) |
Managing Director |
Sterna Biologicals (Genova) (Group) |
Germany |
| Biller, Scott (GV 202204 Executive Venture Partner formerly Agios Pharmaceuticals + Novartis + BMS) |
Board member, non-executive |
Alphabet (formerly Google) (Group) |
United States (USA) |
| Billert, Thomas (Jena Bioscience 2002 Managing Director (COO) joined in 1999) |
Managing Director |
Jena Bioscience GmbH |
Germany |
| Binaschi, Monica (Menarini 201707) |
n. a. |
Menarini (Group) |
Italy |
| Binder, Josef |
n. a. |
University of Bremen |
Germany |
| Binder, Klaus (Coral BioNet 201107 COO of Scil Technology GmbH) |
Chief Operating Officer (COO) |
Coral BioNet (Group) |
Germany |
| Binder, Veronika (Technoclone 201201 CEO) |
Chief Executive Officer (CEO) |
Technoclone (Group) |
Austria |
| Bindseil, Kai-Uwe (BioTop 200503) |
Cluster Manager |
Berlin (govt region) |
Germany |
| Bindseil, Missy (JSR Corporation 201706 Media Contact at JSR Life Sciences) |
Public Relations Manager / Investor Relations Manager |
JSR Corporation (Group) |
Japan |
| Bingler, Dirk (GUS Group 201706 Managing Director of GUS Deutschland GmbH) |
Managing Director |
GUS Group (Group) |
Germany |
| Biniszkiewicz, Detlev (AstraZeneca 201308 VP Oncology iMed Strategy) |
Business Development Manager / Strategy Manager |
AstraZeneca (Group) |
United Kingdom (GB) |
| Binnema, Doede (Healthy Ageing Network Northern Netherlands 201109 Program Manager Food & Nutrition) |
Cluster Manager |
Healthy Ageing Network Northern Netherlands (HANNN) |
Netherlands |
| Binnig, Gerd (Definiens 201210 CTO + Co-founder + Nobel Laureate) |
Chief Technology/Technical Officer (CTO) |
AstraZeneca (Group) |
Germany |
| Binschek-Domaß, Torsten (Berlin (govt) 201503 Head Clinical + Forensic Toxicology Dept at Labor Berlin) |
President/Director/Head of Research Organisation/Unit |
Berlin (govt region) |
Germany |
| Binur, Anat (Ukko 202101 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Ukko Inc. |
United States (USA) |
| Binz, Thomas (MHH 201504 Researcher at Institute for Physiological Chemistry) |
Researcher (university / research institute) |
MHH (Hanover Medical School / Medizinische Hochschule Hannover) |
Germany |
| Biondi, Paul (Flagship Pioneering 201912– Executive Partner before BMS 2002–2019 most recently SVP Strategy + BusDev) |
Partner (venture partner) |
Flagship Pioneering |
United States (USA) |
| Birner, Hubert (TVM 200502–200809–) |
General Partner (venture partner) |
TVM (Group) |
Germany |
| Birnstiel, Constantin (Merck (DE) 201705– Head of Group Communications before Uniper + Osram + Siemens) |
Public Relations Manager / Investor Relations Manager |
Merck (DE) (Group) |
Germany |
| Birr, Christian (Orpegen GmbH 200808 Founder + Managing Director) |
Managing Director |
Orpegen Pharma Gesellschaft für biotechnologische Forschung, Entwicklung & Produktion m.b.H. |
Germany |
| Birrenbach, Iris (bp independent research 200504) |
n. a. |
bp independent research GmbH |
Germany |
| Birsner, Ulrich (GeneScan Europe 200007 CEO) |
Managing Director |
Ava Lifescience GmbH |
Germany |
| Bischof, Matthias (Austria (govt) 201107 Head of Communications at aws) |
Public Relations Manager / Investor Relations Manager |
Austria (govt) |
Austria |
| Bischofberger, Norbert (Kronos Bio 202010 CEO before Gilead Sciences 200903 EVP R&D CSO) |
Chief Executive Officer (CEO) |
Kronos Bio Inc. (Nasdaq: KRON) |
United States (USA) |
| Bischoff, Klaus (Merck (D) 200802 Head Performance & Life Science Chemicals division) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
Germany |
| Bischoff, Ralf (Pepperprint GmbH 201305 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Pepperprint GmbH |
Germany |
| Biselli, Scarlett (Eurofins 201306 Eurofins WEJ Contaminants GmbH) |
n. a. |
Eurofins (Group) |
Germany |
| Bishop, Hans E. (Juno Therapeutics 201601 CEO + Co-Founder before Dendreon + Bayer + GW + SKB) |
Chief Executive Officer (CEO) |
Bristol-Myers Squibb (BMS) (Group) |
United States (USA) |
| Bishop, John L. (Cepheid 200507 CEO) |
Chief Executive Officer (CEO) |
Danaher (Group) |
United States (USA) |
| Biskup, Dirk (CeGAT GmbH 200907– Managing Director + founder) |
Managing Director |
CeGaT (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 5 6 7 ... 81 82 83 
![Picture [iito] No Content Marketing 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-no-content-marketing.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
